●
INZY
Inozyme Pharma, Inc.
$8.00M
Cluster buy
Discretionary Insider Activity
Date:
08/01/2023
Insiders:
Hopfner Robert Lorne, director, and 1 others
Prior trend:
10 weeks of no discretionary insider activity

Summary

A $8.00M cluster buy for Inozyme Pharma, Inc. (INZY) on 08/01/2023 after 10 weeks of no discretionary insider activity.

Reports

Action Amount Date Insider Role(s) SEC Filing No
● Buy $4.00M 08/03/2023 Hopfner Robert Lorne Director 0000950170-23-038268
● Buy $4.00M 08/03/2023 Pivotal bioVenture Partners Fund I, L.P. + 1 Director 0000950170-23-038272

Transactions

Action Amount Date Insider Security Type SEC Code
● Buy $571K 08/01/2023 Hopfner Robert Lorne Common Stock Discretionary Purchase
● Buy $3.43M 08/01/2023 Hopfner Robert Lorne Common Stock Discretionary Purchase
● Buy $571K 08/01/2023 Pivotal bioVenture Partners Fund I, L.P. Common Stock Discretionary Purchase
● Buy $3.43M 08/01/2023 Pivotal bioVenture Partners Fund I, L.P. Common Stock Discretionary Purchase

Metadata

Signal ID:
vMPr2uAaNtFcnBkg
Detected on:
07/31/2023